GALTGalectin Therapeutics Inc.
3.680USD+0.27%Mkt Cap: 371.13M $P/E: —3d ago
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The company's lead product candidate is belapectin (GR-MD-02), …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap371.13M $
Enterprise Value492.92M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-30.84M $
Revenue/Share—
Last Price3.680 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees9
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS3632252025
Valuation
P/E (Trailing)—
P/E (Forward)-2.13
PEG-36.15
EV/EBITDA—
EV/Revenue—
P/S—
P/B-1.70
EPS (TTM)-0.42
EPS (Forward)-1.68
52W Range
2.03032% of range7.130
52W High7.130 USD
52W Low2.030 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE24.44%
ROA-157.87%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.88M $
CapEx (TTM)—
FCF Margin—
FCF Yield-4.00%
Net Debt130.69M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-1.06
Current Ratio0.10
Quick Ratio0.09
Book Value/Sh-2.0970 USD
Cash/Share0.1320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateMar 23, 2012
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.00 USD
Upside (mean)+198.9%
Target Range11.00 USD – 11.00 USD
# Analysts1
Ownership
Shares Out.100.85M
Float47.83M
Insiders53.08%
Institutions15.65%
Short Interest
Short Ratio15.2d
Short % Float11.30%
Short % Out.8.62%
Shares Short8.70M
Short (prev mo.)8.97M
Technical
SMA 503.649 (+0.8%)
SMA 2003.526 (+4.4%)
Beta0.35
S&P 52W Chg18.16%
Avg Vol (30d)480.55K
Avg Vol (10d)348.67K
Technical Indicators
RSI (14)54.9
MACD-0.0319
MACD Signal-0.0925
MACD Hist.+0.0606
BB Upper3.763 USD
BB Middle3.319 USD
BB Lower2.874 USD
BB Width26.79%
ATR (14)0.3141 USD
Vol Ratio (20d)0.46x